CDC-Authored Genomics and Precision Health Publications Database

---

Last data update: Nov 04, 2024. (Total: 6390 publications)

All Cancer Diabetes Economic Equity Environmental FHH HLBS ID Implementation ND PGx PI Rare RCH dataset

Filtered By: Select to fine-tune your search Year Journal

Records 1-20 (of 20 Records)

Query Trace: Mishin VP[original query]
Antiviral susceptibility of swine-origin influenza a viruses isolated from humans, United States Gao R , Pascua PNQ , Chesnokov A , Nguyen HT , Uyeki TM , Mishin VP , Zanders N , Cui D , Jang Y , Jones J , La Cruz J , Di H , Davis CT , Gubareva LV . Emerg Infect Dis 2024 30 (11)
Antiviral susceptibility of clade 2.3.4.4b highly pathogenic avian influenza A(H5N1) viruses isolated from birds and mammals in the United States, 2022 Nguyen HT , Chesnokov A , De La Cruz J , Pascua PNQ , Mishin VP , Jang Y , Jones J , Di H , Ivashchenko AA , Killian ML , Torchetti MK , Lantz K , Wentworth DE , Davis CT , Ivachtchenko AV , Gubareva LV . Antiviral Res 2023 217 105679
Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir. Patel MC , Chesnokov A , Jones J , Mishin VP , De La Cruz JA , Nguyen HT , Zanders N , Wentworth DE , Davis TC , Gubareva LV . Antiviral Res 2021 188 105035
Detection of baloxavir resistant influenza A viruses using next generation sequencing and pyrosequencing methods. Patel MC , Mishin VP , De La Cruz JA , Chesnokov A , Nguyen HT , Wilson MM , Barnes J , Kondor RJG , Wentworth DE , Gubareva LV . Antiviral Res 2020 182 104906
Detection of oseltamivir-resistant zoonotic and animal influenza A viruses using the rapid influenza antiviral resistance test. Hodges EN , Mishin VP , De la Cruz J , Guo Z , Nguyen HT , Fallows E , Stevens J , Wentworth DE , Davis CT , Gubareva LV . Influenza Other Respir Viruses 2019 13 (5) 522-7
Insights into the antigenic advancement of influenza A(H3N2) viruses, 2011-2018. Jorquera PA , Mishin VP , Chesnokov A , Nguyen HT , Mann B , Garten R , Barnes J , Hodges E , De La Cruz J , Xu X , Katz J , Wentworth DE , Gubareva LV . Sci Rep 2019 9 (1) 2676
A Pyrosequencing-Based Approach to High-Throughput Identification of Influenza A(H3N2) Virus Clades Harboring Antigenic Drift Variants. Mishin VP , Baranovich T , Garten R , Chesnokov A , Abd Elal AI , Adamczyk M , LaPlante J , George KS , Fry AM , Barnes J , Chester SC , Xu X , Katz JM , Wentworth DE , Gubareva LV . J Clin Microbiol 2016 55 (1) 145-154
Enhanced genetic characterization of influenza A(H3N2) viruses and vaccine effectiveness by genetic group, 2014-2015. Flannery B , Zimmerman RK , Gubareva LV , Garten RJ , Chung JR , Nowalk MP , Jackson ML , Jackson LA , Monto AS , Ohmit SE , Belongia EA , McLean HQ , Gaglani M , Piedra PA , Mishin VP , Chesnokov AP , Spencer S , Thaker SN , Barnes JR , Foust A , Sessions W , Xu X , Katz J , Fry AM . J Infect Dis 2016 214 (7) 1010-9
The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. Yang H , Carney PJ , Mishin VP , Guo Z , Chang JC , Wentworth DE , Gubareva LV , Stevens J . J Virol 2016 90 (12) 5770-5784
Application of a Seven-Target Pyrosequencing Assay To Improve the Detection of Neuraminidase Inhibitor-Resistant Influenza A(H3N2) Viruses. Tamura D , Okomo-Adhiambo M , Mishin VP , Guo Z , Xu X , Villanueva J , Fry AM , Stevens J , Gubareva LV . Antimicrob Agents Chemother 2015 59 (4) 2374-9
Antiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011 Nguyen HT , Nguyen T , Mishin VP , Sleeman K , Balish A , Jones J , Creanga A , Marjuki H , Uyeki TM , Nguyen DH , Nguyen DT , Do HT , Klimov AI , Davis CT , Gubareva LV . Emerg Infect Dis 2013 19 (12) 1963-71
The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Mishin VP , Sleeman K , Levine M , Carney PJ , Stevens J , Gubareva LV . Antiviral Res 2013 101 93-6
Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment Tamura D , Nguyen HT , Sleeman K , Levine M , Mishin VP , Yang H , Guo Z , Okomo-Adhiambo M , Xu X , Stevens J , Gubareva LV . Antimicrob Agents Chemother 2013 57 (12) 6141-6
Bioluminescence-based neuraminidase inhibition assay for monitoring influenza drug susceptibility in clinical specimens Marjuki H , Mishin VP , Sleeman K , Okomo-Adhiambo M , Sheu TG , Guo L , Xu X , Gubareva LV . Antimicrob Agents Chemother 2013 57 (11) 5209-15
Analysis of influenza viruses from patients clinically suspected of infection with an oseltamivir resistant virus during the 2009 pandemic in the United States. Nguyen HT , Trujillo AA , Sheu TG , Levine M , Mishin VP , Shaw M , Ades EW , Klimov AI , Fry AM , Gubareva LV . Antiviral Res 2012 93 (3) 381-6
Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein Alymova IV , Portner A , Mishin VP , McCullers JA , Freiden P , Taylor GL . Glycobiology 2012 22 (2) 174-80
Detection of hemagglutinin variants of the pandemic influenza A (H1N1) 2009 virus by pyrosequencing. Levine M , Sheu TG , Gubareva LV , Mishin VP . J Clin Microbiol 2011 49 (4) 1307-12
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro Gubareva LV , Trujillo AA , Okomo-Adhiambo M , Mishin VP , Deyde VM , Sleeman K , Nguyen HT , Sheu TG , Garten RJ , Shaw MW , Fry AM , Klimov AI . Antivir Ther 2010 15 (8) 1151-9
Neuraminidase inhibitor susceptibility testing in human influenza viruses: a laboratory surveillance perspective Okomo-Adhiambo M , Sleeman K , Ballenger K , Nguyen HT , Mishin VP , Sheu TG , Smagala J , Li Y , Klimov AI , Gubareva LV . Viruses 2010 2 (10) 2269-2289
Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays Nguyen HT , Sheu TG , Mishin VP , Klimov AI , Gubareva LV . Antimicrob Agents Chemother 2010 54 (9) 3671-7